NCT04429971View on ClinicalTrials.gov

Pre-Exposure Prophylaxis in the Emergency Department

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 18, 2020

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
HIV/AIDSPrEP
Interventions
OTHER

PrEP screening program

ICAP Pre-Exposure Prophylaxis (PrEP) Screening for Substantial Risk and Eligibility tool

OTHER

PrEP starter pack

emtricitabine/tenofovir alafenamide or emtricitabine/tenofovir disoproxil

Trial Locations (1)

10003

Mount Sinai Beth Israel Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04429971 - Pre-Exposure Prophylaxis in the Emergency Department | Biotech Hunter | Biotech Hunter